stockrowBioCryst Pharmaceuticals, Inc.
BCRX Healthcare Drug Manufacturers Specialty & Generic
BioCryst Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $874.8 million, up 94.1% from fiscal 2024.
- Revenue
- +13.1%
- EPS
- +150.0%
- Free cash flow
- −18.7%
- Total debt
- +15.2%
Quarter to September 2026, against a year earlier
Follow BCRX
Alert me
BioCryst Pharmaceuticals, Inc. (BCRX) Book value per share
BioCryst Pharmaceuticals, Inc.'s book value per share at the end of fiscal 2025 was −0.6×, compared with −2.3× in fiscal 2024. At the end of the quarter to 30 September 2026 it was −1.6×. Over the past ten years it has ranged from −2.4× (fiscal 2023) to 1.0× (fiscal 2017); the current reading is higher than 45% of that period. BioCryst Pharmaceuticals, Inc. ranks 82nd of 84 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | −0.6× | — |
| FY2024 | −2.3× | — |
| FY2023 | −2.4× | — |
| FY2022 | −1.6× | — |
| FY2021 | −0.6× | — |
| FY2020 | −0.1× | — |
| FY2019 | 0.3× | (30.66%) |
| FY2018 | 0.5× | (51.89%) |
| FY2017 | 1.0× | 4,535.05% |
| FY2016 | 0.0× | (96.73%) |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | −1.6× | — |
| Jun 2026 | −1.8× | — |
| Mar 2026 | −2.3× | — |
| Dec 2025 | −0.6× | — |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| PBH Prestige Consumer Healthcare Inc. compare | 40.9× |
| ANIP ANI Pharmaceuticals, Inc. compare | 30.0× |
| PRGO Perrigo Company plc compare | 17.5× |
| TRLV Trulieve Cannabis Corp. compare | 4.0× |
| XERS Xeris Biopharma Holdings, Inc. compare | 0.3× |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 0.0× |
| RGC Regencell Bioscience Holdings Limited compare | 0.0× |
| ALVO Alvotech compare | 0.0× |
| BCRX BioCryst Pharmaceuticals, Inc. | −1.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on BCRX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement